Tenax Therapeutics's market cap is currently $29.34M. The company's EPS TTM is $-0.27; its P/E ratio is ―; Tenax Therapeutics is scheduled to report earnings on August 13, 2025, and the estimated EPS forecast is $-0.31. See an overview of income statement, balance sheet, and cash flow financials.
